Viveve Medical, Inc.
VIVE · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $72,525 | $69,804 | $112,573 | $115,023 |
| - Cash | $6 | $9 | $14 | $19 |
| + Debt | $6 | $6 | $6 | $5 |
| Enterprise Value | $72,525 | $69,800 | $112,564 | $115,009 |
| Revenue | $2 | $2 | $2 | $2 |
| % Growth | -6.2% | 9.4% | -3.8% | – |
| Gross Profit | $1 | $0 | $0 | -$0 |
| % Margin | 32.4% | 16.4% | 19.5% | -2.4% |
| EBITDA | -$5 | -$5 | -$5 | -$6 |
| % Margin | -267.8% | -271.4% | -322.4% | -337.3% |
| Net Income | -$5 | -$6 | -$6 | -$6 |
| % Margin | -314.1% | -341.1% | -376.4% | -370.9% |
| EPS Diluted | -0.5 | -0.58 | -0.58 | -0.63 |
| % Growth | 13.8% | 0% | 7.9% | – |
| Operating Cash Flow | -$3 | -$5 | -$5 | -$3 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$4 | -$5 | -$5 | -$4 |